Abstract Library

#1873 Meta-Analysis of Liver Resection versus Nonsurgical Treatments for Pancreatic Neuroendocrine Tumors with Liver Metastases

Introduction: Available data comparing the efficacy of different treatment regiments are rarely found. No meta-analyses have compared live resection with other nonsurgical treatments in resectable liver metastases from pNETs.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Yuan C,

Keywords: meta-analysis, pancreatic neuroendocrine tumors (p-NETs) , liver metastasis, liver resection,

#1811 Safety and Tolerability of Lanreotide Autogel/Depot (LAN) in Patients (pts) with Neuroendocrine Tumours (NETs): Pooled Analysis of Clinical Studies

Introduction: Two randomized double-blind (DB) trials demonstrated the efficacy of LAN 120mg/4weeks vs placebo in NETs: PFS improved in metastatic non-functioning intestinal/pancreatic NETs (CLARINET); less rescue medication used for carcinoid syndrome (CS) (ELECT).

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Phan A, Wolin E, Fisher G, Ruszniewski P, Pavel M,

Keywords: Lanreotide, safety,

#1602 Systematic Review of Resecting Primary Tumor in MNETs Patients with Unresectable Liver Metastases

Introduction: Treatment for midgut neuroendocrine tumors (MNETS) with unresectable liver metastasis has long been a controversial issue.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Zhao H

Authors: Guo J, Bi X, Zhou J, Li Z, Huang Z,

Keywords: midgut neuroendocrine tumor, liver metastasis, primary tumor resection,

#661 Telotristat Etiprate Produces Clinical and Biochemical Responses in Patients with Carcinoid Syndrome: Results of a Phase 2, Multicenter, Open-label, Serial-Ascending Study

Introduction: Excess serotonin (5-HT) in patients (pts) with carcinoid syndrome (CS) is associated with symptoms including increased bowel movement (BM) frequency.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Pavel M, Wiedenmann B, Caplin M, Hörsch D, Freiman J,

Keywords: symptom relief, diarrhea,

#133 Effectiveness of transarterial embolization of liver neuroendocrine metastases

Introduction: Neuroendocrine tumors (NETs) with diffuse liver metastases have a poor prognosis and prove difficult to palliate. Somatostatin analogues and chemotherapy have been used but often are poorly tolerated and may not provide symptom relief. Transarterial Embolization (TAE) is being increasingly used to improve symptom control and reduce tumor size. We looked at the last 5-year experience of TAE in patients with hepatic metastases from neuroendocrine tumors.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Mandair D, Bridgestock H, Shah T, Mangat K, Oliff S,

Keywords: neuroendocrine tumor, carcinoid syndrome, transarterial embolization, symptom control,